Bulletin
Investor Alert

Edwards Lifesciences Corp.

NYS: EW

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 28, 2020, 6:29 p.m.

EW
/zigman2/quotes/205745196/composite

$

77.29

Change

-0.42 -0.54%

Volume

Volume 23,802

Quotes are delayed by 20 min

/zigman2/quotes/205745196/composite

Today's close

$ 77.45

$ 77.71

Change

+0.26 +0.34%

Day low

Day high

$77.49

$78.72

Open

52 week low

52 week high

$51.51

$87.79

Open

Annual Financials for Edwards Lifesciences Corp.

Fiscal year is January-December. All values USD millions. 20152016201720182019 5-year trend
Sales/Revenue 2.49B2.96B3.44B3.72B4.35B
Cost of Goods Sold (COGS) incl. D&A 684.3M805.8M882.9M922.1M1.16B
COGS excluding D&A 618.5M734.6M801M844.7M1.04B
Depreciation & Amortization Expense 65.8M71.2M81.9M77.4M114.6M
Depreciation 58.7M63.6M74.1M74.9M110M
Amortization of Intangibles 7.1M7.6M7.8M2.5M4.6M
Gross Income 1.81B2.16B2.55B2.8B3.19B
20152016201720182019 5-year trend
SG&A Expense 1.23B1.34B1.54B1.71B1.99B
Research & Development 383.1M442.2M552.6M622.2M752.7M
Other SG&A 850.4M900.2M982.6M1.09B1.24B
Other Operating Expense -----
Unusual Expense 400,00064.9M(3.2M)313.7M92.2M
EBIT after Unusual Expense (400,000)750.6M1.02B778.6M1.11B
Non Operating Income/Expense 57.4M(5.5M)16.3M(15.8M)55.9M
Non-Operating Interest Income 7.9M10.8M20.3M32M32.2M
Equity in Affiliates (Pretax) -----
Interest Expense 18.4M18M22.1M33.4M27.3M
Gross Interest Expense 18.4M18M22.1M33.4M27.3M
Interest Capitalized -----
Pretax Income 622.4M737.9M1.03B761.4M1.17B
Income Tax 127.5M168.4M451.3M39.2M119.6M
Income Tax - Current Domestic 109.8M165.5M363.6M24.5M80M
Income Tax - Current Foreign 33.5M27.4M60.6M35.9M29.1M
Income Tax - Deferred Domestic (15.1M)(23.9M)35.5M(38.5M)10M
Income Tax - Deferred Foreign (700,000)(600,000)(8.4M)17.3M500,000
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income 494.9M569.5M583.6M722.2M1.05B
Minority Interest Expense -----
Net Income 494.9M569.5M583.6M722.2M1.05B
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 494.9M569.5M583.6M722.2M1.05B
Preferred Dividends -----
Net Income Available to Common 494.9M569.5M583.6M722.2M1.05B
EPS (Basic) 0.770.890.921.151.68
Basic Shares Outstanding 646.5M639M632.7M627.6M624.9M
EPS (Diluted) 0.750.870.901.131.64
Diluted Shares Outstanding 660.9M653.4M647.7M640.8M636.6M
EBITDA 641.7M886.7M1.1B1.17B1.31B
Link to MarketWatch's Slice.